Cargando…

Renewable, recombinant antibodies to histone post-translational modifications

Variability in the quality of antibodies to histone post-translational modifications (PTMs) presents widely recognized hindrance in epigenetics research. Here, by using antibody engineering technologies we produced recombinant antibodies directed to the trimethylated lysine residues of histone H3 wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Takamitsu, Taft, Joseph M., Swist, Kalina M., Luo, Hao, Witt, Heather, Slattery, Matthew, Koide, Akiko, Ruthenburg, Alexander J., Krajewski, Krzysztof, Strahl, Brian D., White, Kevin P., Farnham, Peggy J., Zhao, Yingming, Koide, Shohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828030/
https://www.ncbi.nlm.nih.gov/pubmed/23955773
http://dx.doi.org/10.1038/nmeth.2605
_version_ 1782291178660560896
author Hattori, Takamitsu
Taft, Joseph M.
Swist, Kalina M.
Luo, Hao
Witt, Heather
Slattery, Matthew
Koide, Akiko
Ruthenburg, Alexander J.
Krajewski, Krzysztof
Strahl, Brian D.
White, Kevin P.
Farnham, Peggy J.
Zhao, Yingming
Koide, Shohei
author_facet Hattori, Takamitsu
Taft, Joseph M.
Swist, Kalina M.
Luo, Hao
Witt, Heather
Slattery, Matthew
Koide, Akiko
Ruthenburg, Alexander J.
Krajewski, Krzysztof
Strahl, Brian D.
White, Kevin P.
Farnham, Peggy J.
Zhao, Yingming
Koide, Shohei
author_sort Hattori, Takamitsu
collection PubMed
description Variability in the quality of antibodies to histone post-translational modifications (PTMs) presents widely recognized hindrance in epigenetics research. Here, by using antibody engineering technologies we produced recombinant antibodies directed to the trimethylated lysine residues of histone H3 with high specificity and affinity and no lot-to-lot variation. These recombinant antibodies performed well in common epigenetics applications, and their high specificity enabled us to identify positive and negative correlations among histone PTMs.
format Online
Article
Text
id pubmed-3828030
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-38280302014-04-01 Renewable, recombinant antibodies to histone post-translational modifications Hattori, Takamitsu Taft, Joseph M. Swist, Kalina M. Luo, Hao Witt, Heather Slattery, Matthew Koide, Akiko Ruthenburg, Alexander J. Krajewski, Krzysztof Strahl, Brian D. White, Kevin P. Farnham, Peggy J. Zhao, Yingming Koide, Shohei Nat Methods Article Variability in the quality of antibodies to histone post-translational modifications (PTMs) presents widely recognized hindrance in epigenetics research. Here, by using antibody engineering technologies we produced recombinant antibodies directed to the trimethylated lysine residues of histone H3 with high specificity and affinity and no lot-to-lot variation. These recombinant antibodies performed well in common epigenetics applications, and their high specificity enabled us to identify positive and negative correlations among histone PTMs. 2013-08-18 2013-10 /pmc/articles/PMC3828030/ /pubmed/23955773 http://dx.doi.org/10.1038/nmeth.2605 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Hattori, Takamitsu
Taft, Joseph M.
Swist, Kalina M.
Luo, Hao
Witt, Heather
Slattery, Matthew
Koide, Akiko
Ruthenburg, Alexander J.
Krajewski, Krzysztof
Strahl, Brian D.
White, Kevin P.
Farnham, Peggy J.
Zhao, Yingming
Koide, Shohei
Renewable, recombinant antibodies to histone post-translational modifications
title Renewable, recombinant antibodies to histone post-translational modifications
title_full Renewable, recombinant antibodies to histone post-translational modifications
title_fullStr Renewable, recombinant antibodies to histone post-translational modifications
title_full_unstemmed Renewable, recombinant antibodies to histone post-translational modifications
title_short Renewable, recombinant antibodies to histone post-translational modifications
title_sort renewable, recombinant antibodies to histone post-translational modifications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828030/
https://www.ncbi.nlm.nih.gov/pubmed/23955773
http://dx.doi.org/10.1038/nmeth.2605
work_keys_str_mv AT hattoritakamitsu renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT taftjosephm renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT swistkalinam renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT luohao renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT wittheather renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT slatterymatthew renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT koideakiko renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT ruthenburgalexanderj renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT krajewskikrzysztof renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT strahlbriand renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT whitekevinp renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT farnhampeggyj renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT zhaoyingming renewablerecombinantantibodiestohistoneposttranslationalmodifications
AT koideshohei renewablerecombinantantibodiestohistoneposttranslationalmodifications